Skip to content

Elanco Animal Health

US · ELAN #1381 by market cap Listed 2018
25.74 -0.55 -2.09%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

About Elanco Animal Health

Elanco Animal Health, Inc. develops, manufactures, and markets products for pets and farm animals. Its products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, TruCan, AviPro, Baytril, Catosal, Denagard, and Experior. The company was founded in 1954 and is headquartered in Indianapolis, IN.

Founded
1954
CEO
Mr. Jeffrey N. Simmons
Employees
9,400
Headquarters
Indianapolis, Indiana, United States of America
Fiscal year end
12-31
Website
elanco.com

Company profile

Exchange
US
Symbol
ELAN
Market-cap rank
#1381
Listing date
2018-09-21
Market cap
12.87B
Float cap
12.76B
Shares out
499.83M
Float shares
495.70M

Sectors & themes

Drug Manufacturers - Specialty & Generic Global medical industry Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 20:02:31 · For reference only, not investment advice and not tailored to your situation.

Elanco Animal Health discussion 0 comments

Add a comment